BIODESIX, INC. Amortization of Debt Issuance Costs
BIODESIX, INC. (BDSX) reported Amortization of Debt Issuance Costs of $41.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2021-05-11
- BIODESIX, INC. amortization of debt issuance costs for the quarter ending 2021-03-31 was $41.00K, a 13.89% increase year-over-year.
- BIODESIX, INC. amortization of debt issuance costs for the quarter ending 2020-12-31 was $35.00K, a 0.00% change year-over-year.
- BIODESIX, INC. amortization of debt issuance costs for the quarter ending 2020-03-31 was $36.00K.
- BIODESIX, INC. amortization of debt issuance costs for the quarter ending 2019-12-31 was $35.00K.
- BIODESIX, INC. amortization of debt issuance costs for fiscal 2020 was $144.00K, a 0.00% change from fiscal 2019.
- BIODESIX, INC. amortization of debt issuance costs for fiscal 2019 was $144.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-03-31 | $41.00K 10-Q · filed 2021-05-11 | $76.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $144.00K 10-K · filed 2021-03-16 | ||
| 2020-09-30 | $109.00K 10-Q · filed 2020-12-10 | |||
| 2020-03-31 | $36.00K 10-Q · filed 2021-05-11 | $71.00K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $144.00K 10-K · filed 2021-03-16 | ||
| 2019-09-30 | $109.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |